Identification of monosomy 3 in choroidal melanoma by chromosome in situ hybridisation

British Journal of Ophthalmology

Volumn 88, Issue 12, 2004, Pages 1527-1532

  Sandinha, M T ^a   Farquharson, M A ^b   Roberts, Fiona ^c  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FORMALDEHYDE; GLUTARALDEHYDE; PARAFFIN;

ADOLESCENT; ADULT; ARTICLE; CENTROMERE; CHILD; CHOROID MELANOMA; CHROMOSOME 18; CHROMOSOME 3; CHROMOSOME IMBALANCE; CHROMOSOME IN SITU HYBRIDIZATION; CHROMOSOME INDEX; CHROMOSOME NUMBER; CONTROLLED STUDY; CYTOGENETICS; DNA PROBE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; METASTASIS; MONOSOMY; MONOSOMY 3; PRIORITY JOURNAL; PROGNOSIS; SIGNAL DETECTION; SIGNAL DISTRIBUTION; SURVIVAL; TISSUE SECTION; TUMOR NECROSIS;

ADOLESCENT; ADULT; CHILD; CHOROID NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 3; FIXATIVES; FORMALDEHYDE; GLUTARAL; HUMANS; IN SITU HYBRIDIZATION; MELANOMA; MONOSOMY; NEOPLASM METASTASIS; RETINA; SKIN;

EID: 9644276670     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.044768     Document Type: Article

References (29)

1. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmol 2003;110:956-61.
2. Diener-West M, Hawkins BS, Markowitz JA, et al. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;110:245-50.
3. Bergman L, Seregard S, Nilsson B, et al. Uveal melanoma survival in Sweden from 1960 to 1998. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Invest Ophthalmol Vis Sci 2003;44:3282-7.
4. Kath R, Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993;72:2219-23.
5. Newton FH. Malignant melanoma of choroid. Report of a case with clinical history of 36 years and follow up of 32 years. Arch Ophthalmol 1965;73:198-9.
6. Aalto Y, Eriksson L, Seregard S, et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1,6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:313-17.
7. Scholes AGM, Liloglou T, Maloney P, et al. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus in uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:2472-7.
8. Sisley K, Parsons MA, Garnham J, et al. Association of specific chromosome alternations with tumour phenotype in posterior uveal melanoma. Br J Cancer 2000;82:330-8.
9. White VA, Chambers JD, Courtright PD, et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma, Cancer 1998;83:354-9.
10. Naus NC, Verhoeven AC, van Drunen E, et al. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Clin Cancer Res 2002;8:534-9.
11. Patel KA, Edmondson ND, Talbot F, et al. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol 2001;85:1440-4.
12. Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44:1008-11.
13. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-5.
14. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997;19:22-8.
15. Horsman DE, White VA. Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q. Cancer 1993;71:811-19.
16. Sisley K, Rennie IG, Cottam DW, et al. Cytogenetic findings in six posterior uvea melanomas: involvement of chromosomes 3, 6, and 8. Genes Chromosomes Cancer 1990;2:205-9.
17. Speicher MR, Prescher G, du Manoir S, et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 1994;54:3817-23.
18. Hopman AH, Poddighe PJ, Moesker O, et al. In: Herrington CS, McGee JOD, eds. Diagnostic molecular pathology: a practical approach. Arlington, VA: IRL Press, 1992:141-67.
19. Murphy DS, Hoare SF, Going JJ, et al. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 1995;87:1694-704.
20. Dhingra K, Sneige N, Pandita TK, et al. Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. Cytometry 1994;16:100-12.
21. Russell AJ, Sibbald J, Haak H, et al. Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage. Br J Cancer 1999;81:684-9.
22. Bulten J, Poddighe PJ, Robben JCM, et al. Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 1998;152:495-503.
23. Sneige N, Sahin A, Dinh M, et al. Interphase cytogenetics in mammographically detected breast lesions. Hum Pathol 1996;27:330-5.
24. Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer 1996;77:315-20.
25. Tsechentscher F, Prescher G, Horsman DE, et al. Partial deletions of the long and short arm of chromosome 3 point to two suppressor genes in uveal melanoma. Cancer Res 2001;61:3439-42.
26. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 1999;59:3032-7.
27. McNamara M, Felix C, Davison EV, et al. Assessment of chromosome 3 copy number by fluorescence in situ hybridization and comparative genomic hybridization. Cancer Genet Cytogenet 1997;98:4-8.
28. Walker TM, van Ginkel PR, Gee RL, et al. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol 2002;120:1719-25.
29. Ried T. Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am J Pathol 1998;152:325-7.